-
DiscoveryCancer cocktails: LJM716 – closing a common release valve
Discovery -
DiscoveryCancer cocktails: ABL001 – hitting one target twice
Discovery -
From Our LabsmHealth: A revolution in healthcare
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
From Our Labs -
Patient PerspectivesExperts call for new approach to patient and physician management of type 2 diabetes
A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.
Patient Perspectives -
DiscoveryCombination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
Discovery -
From Our LabsWhy Novartis scouts for disruptive technology
Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.
From Our Labs -
Patient PerspectivesMost Europeans have limited awareness about heart failure
The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.
Patient Perspectives -
From Our LabsRobots speed the pace of modern drug discovery
Novartis researchers use automation to rapidly identify starting points for new drugs.
From Our Labs -
Patient PerspectivesLiving with heart failure
Heart failure affects 26 million people worldwide. More people die from heart failure than from some advanced cancers, including breast and bowel cancer.
Patient Perspectives -
Access to Healthcare2 million kids receive malaria medicine
Ahead of World Malaria Day, Novartis and Malaria No More delivered 2 million pediatric antimalarials to Zambia provided through the Power of One campaign.
Access to Healthcare -
Access to HealthcareSight savers jet to the rescue
Up the stairs to the entrance of the plane they climb: small children with cloudy eyes, teens with thick glasses and practiced squints, adults with dark shades.
Access to Healthcare -
From Our LabsSleuths use hi-tech sensors to fight pharmaceutical crime
Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.
From Our Labs